Hvsen Biotechnology Co., Ltd.

SZSE:300871.SZ

14.16 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q2
Assets:
Current Assets:
Cash & Cash Equivalents 237.279350.8286.068293.61200.426362.696395.545424.044323.048310.246682.341,068.234456.601537.824465.241345.343978.468155.702-104.456104.456124.187
Short Term Investments 232.304205.255286.164304.257405.948380.536393.41361.677514.302491.791272.10430.216-041.505151.122240.63300208.91200
Cash and Short Term Investments 469.583556.055572.232597.867606.374743.232788.955785.722837.35802.037954.4441,098.45456.601579.329616.362585.977978.468155.702104.456104.456124.187
Net Receivables 421.35353.581378.414376.64351.003320.221338.953354.411275.769255.597261.506249.397235.499231.874263.983235.4174.479144.6170106.53181.758
Inventory 251.244288.951278.952228.67237.614249.543217.507199.006179.264223.473201.969231.551211.794232.771178.604127.268101.34899.003072.41696.02
Other Current Assets 67.12936.43148.00662.80412.40413.19723.212.33626.38226.88813.8419.48435.004089.764228.50733.002146.6709.13984.936
Total Current Assets 1,209.3071,235.0181,277.6041,265.9811,207.3941,326.1931,368.6151,351.4751,318.7651,307.9951,431.7581,598.882938.8971,063.9331,148.7131,177.1521,287.297401.375104.456292.543305.142
Non-Current Assets:
Property, Plant & Equipment, Net 1,547.8321,552.4841,561.8961,566.1591,562.7141,511.131,517.0071,498.0791,312.8191,234.8961,118.1331,006.798867.009637.107461.824412.329311.875268.2980233.306156.776
Goodwill 000000000000000000000
Intangible Assets 113.725114.162115.139104.172104.836105.504106.181106.874107.658108.458109.259110.059110.86111.51495.15695.77196.20496.839098.18962.661
Goodwill and Intangible Assets 113.725114.162115.139104.172104.836105.504106.181106.874107.658108.458109.259110.059110.86111.51495.15695.77196.20496.839098.18962.661
Long Term Investments 10.64110.81610.9913.88214.36811.80212.01812.2340.4130.454000.5842.0542.032.0071.4431.4101.3770.02
Tax Assets 25.54424.6722.59121.65315.09613.28113.94712.9111.20811.31111.10410.4611.0769.5099.3758.2519.5339.11809.1494.459
Other Non-Current Assets 5.4833.9215.6183.6136.7387.6586.6767.54319.94618.52431.23715.46346.59653.75271.26756.71554.9635.219-104.45615.51812.133
Total Non-Current Assets 1,703.2261,706.0531,716.2341,709.481,703.7521,649.3761,655.831,637.6391,452.0441,373.6441,269.7331,142.781,036.124813.936639.651575.074474.015410.885-104.456357.538236.048
Total Assets 2,912.5332,941.0712,993.8382,975.462,911.1462,975.5683,024.4452,989.1142,770.8092,681.6392,701.4912,741.6621,975.0221,877.8691,788.3641,752.2261,761.312812.260650.081541.19
Liabilities & Equity:
Current Liabilities:
Account Payables 224.614369.125380.414472.469405.987428.5477.164489.703335.261332.782276.765249.115269.278293.783188.624194.437176.58164.0010121.0576.118
Short Term Debt 592.494339.021320.348240.587241.013305.227257.018220.085180.911112.129146.393112.83390505063838302944.723
Tax Payables 00.5192.1418.1355.4043.91510.03812.9228.8283.9836.654.8669.8677.23212.7839.0899.3955.551011.4913.8
Deferred Revenue 16.72314.25414.42364.17467.70259.07667.38385.21770.77256.645112.70576.08366.61149.46349.77855.20555.28436.43033.81820.22
Other Current Liabilities 59.29672.86894.37359.8862.05149.44151.18366.59868.05346.98796.038122.58665.5465.5466.70716.9455.38254.70408.40824.891
Total Current Liabilities 893.126781.534797.276781.076722.158801.327811.454804.925593.053506.89538.211503.269446.407406.024307.892338.672343.68307.2560203.767149.531
Non-Current Liabilities:
Long Term Debt 527.025656.743609.142601.657596.914587.827579.014570.36564.445555.854547.504574.56528.8091.9543.991059.643.6033.729.8
Deferred Revenue Non-Current 60.14961.95860.71562.33963.08255.60354.70748.88950.01550.4546.46942.0842.72531.43530.58824.70322.85923.088023.5472.507
Deferred Tax Liabilities Non-Current 7.9749.95416.07820.26219.98720.78621.29121.8181.3970-00000-6.4175.0616.719010.0357.79
Other Non-Current Liabilities 0.84562.8030.8450.8451.6957.2931.691.692.53553.3452.89544.9752.5353.2853.2859.7020.750.75024.2970.75
Total Non-Current Liabilities 595.993667.542686.78685.103681.674665.906656.702642.757618.392609.198596.868619.53974.06936.67537.86434.40488.2774.157068.03240.847
Total Liabilities 1,489.1191,449.0761,484.0561,466.1791,403.8311,467.2331,468.1561,447.6821,211.4451,116.0881,135.081,122.808520.476442.698345.756373.076431.949381.4130271.799190.378
Equity:
Preferred Stock 000000000000000000000
Common Stock 165.766165.764165.887165.887165.887165.887166.055166.055166.054166.054166.249166.249166.249165.761110.507110.507110.50782.807082.80782.807
Retained Earnings 249.731245.511325.537341.942342.049343.07391.077376.221353.296333.402328.849381.853386.037367.636375.073311.616269.654225.2750172.71149.802
Accumulated Other Comprehensive Income/Loss 1,024.595180.3961,036.533179.8651,051.8177.7931,054.888177.8051,076.672199.6061,080.83199.607911.77630.14957.027-0-00378.28100
Other Total Stockholders Equity -17.4041,018.462892.0111,001.451999.379821.586-55.731821.351-36.6571,066.095920.1061,070.752-9.516901.7740957.0270122.7650122.765118.204
Total Shareholders Equity 1,422.6871,429.7371,509.7821,509.2811,507.3151,508.3351,556.2891,541.4321,559.3641,565.5511,566.4121,618.8541,454.5461,435.171,442.6071,379.151,329.362430.847378.281378.281350.813
Total Equity 1,423.4141,430.0361,509.7821,509.2811,507.3151,508.3351,556.2891,541.4321,559.3641,565.5511,566.4121,618.8541,454.5461,435.171,442.6071,379.151,329.362430.847378.281378.281350.813
Total Liabilities & Shareholders Equity 2,912.5332,941.0712,993.8382,975.462,911.1462,975.5683,024.4452,989.1142,770.8092,681.6392,701.4912,741.6621,975.0221,877.8691,788.3641,752.2261,761.312812.26378.281650.081541.19